Metrics as of 10/13/2026, 06:49 PM (Berlin time), refresh in progress.
Cronos Group Stock
Cronos Group Inc.
Company data
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Country
- Canada
- CEO
- Michael Ryan Gorenstein
- Employees
- 610
- Market cap
- $1.2 B
- IPO
- 27/02/2018
Cronos Group Inc. is a company primarily focused on cannabinoids within the Healthcare sector. Founded in 2012, the company is headquartered in Toronto, Canada. The business model involves developing, promoting, and supplying hemp-derived wellness and beauty products under the Lord Jones and Happy Dance brands,…
Company description based on the data provider's company data, AI-assisted, created on 17/10/2026. Not investment advice.
Cronos Group stock: price history
1D
-0.3%
1W
-1.5%
1M
-1.5%
6M
+17.3%
YTD
+21.3%
1Y
+26.1%
2Y
+45.0%
5Y
-41.8%
10Y
+254.4%
Next earnings date
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~6% weaker price swings than usual
Ask the agents about Cronos Group
Analyst assessment of Cronos Group
PRICE TARGET LOW
US$2.30
CONSENSUS
US$3.15
MEDIAN
US$2.90
PRICE TARGET HIGH
US$4.50
0
STRONG BUY
3
BUY
9
HOLD
3
SELL
0
STRONG SELL
15
TOTAL · Hold
As of: 15/05/2024
Cronos Group stock metrics
P/E
16.99
P/B
1.12
EV/EBITDA
13.4
RETURN ON EQUITY
3.0%
NET MARGIN
60.5%
DEBT/EQUITY
0
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
51.4%
FLOAT SHARES
192,237,909
AVG. DAILY VOLUME (30D)
812,588
Insider transactions (SEC)
Buggy Shannon
Buggy Shannon
Doucet Terrence Gregory Joseph
Doucet Terrence Gregory Joseph
Wagner Adam
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -0.3%
Forums (Reddit)
Institutional holders
Comparable stocks
Frequently asked questions about Cronos Group stock
What does Cronos Group do?
Cronos Group Inc. is a company in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry, headquartered in Canada.
The CEO is Michael Ryan Gorenstein, the company employs around 610 people.
The IPO was on 27/02/2018; the stock trades on NASDAQ under the ticker CRON.
What do analysts say about Cronos Group stock?
15 analysts rate the stock, the consensus is Hold (as of 15/05/2024).
The average price target is US$3.15, ranging from US$2.30 to US$4.50, with a median of US$2.90.
This is an external assessment, not a statement by Market Jury.
When does Cronos Group report next?
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly -6% stronger than usual.
Does Cronos Group pay a dividend?
No, Cronos Group currently does not pay a dividend.
Which stocks are comparable to Cronos Group?
Comparable stocks include Merck, Takeda Pharmaceutical Company, Teva Pharmaceutical Industries, Zoetis, Sandoz Group, Viatris, Lantheus Holdings and Amneal Pharmaceuticals.
How can I get Cronos Group stock analyzed?
Clicking "Analyze stock" lets five strategies assess Cronos Group against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.